Literature DB >> 21961857

Complications associated with the treatment for spinal ependymomas.

Daniel T Nagasawa1, Zachary A Smith, Nicole Cremer, Christina Fong, Daniel C Lu, Isaac Yang.   

Abstract

Spinal cord ependymomas are rare neoplasms, comprising approximately 5% of all CNS tumors and 15% of all spinal cord tumors. Although surgery was once reserved for diagnosis alone, the evolution of surgical practices has elevated resection to the treatment of choice for these lesions. While technological advances continue to improve the capacity for gross-total resections and thus decrease the risk of recurrence, ependymoma spinal surgery still contains a variety of potential complications. The presence of neurological deficits and deterioration are not uncommonly associated with spinal cord ependymoma surgery, including sensory loss, dorsal column dysfunction, dysesthetic syndrome, and bowel and bladder dysfunction, particularly in the immediate postoperative period. Surgical treatment may also lead to wound complications and CSF leaks, with increased risk when radiotherapy has been involved. Radiation therapy may also predispose patients to radiation myelopathy and ultimately result in neurological damage. Additionally, resections of spinal ependymomas have been associated with postoperative spinal instability and deformities, particularly in the pediatric population. Despite the advances in microsurgical techniques and intraoperative cord monitoring modalities, there remain a number of serious complications related to the treatment of spinal ependymoma tumors. Identification and acknowledgment of these potential problems may assist in their prevention, early detection, and increased quality of life for patients afflicted with this disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21961857     DOI: 10.3171/2011.7.FOCUS11158

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  16 in total

1.  National trends in management of adult myxopapillary ependymomas.

Authors:  Daphne B Scarpelli; Claire B Turina; Patrick D Kelly; Arpine Khudanyan; Jerry J Jaboin; Shearwood McClelland
Journal:  J Clin Neurosci       Date:  2020-01-24       Impact factor: 1.961

2.  Natural history of intramedullary spinal cord ependymoma in patients preferring nonoperative treatment.

Authors:  Bedjan Behmanesh; Florian Gessler; Stephan Dützmann; Daniel Dubinski; Lioba Imoehl; Volker Seifert; Matthias Setzer; Gerhard Marquardt
Journal:  J Neurooncol       Date:  2017-06-30       Impact factor: 4.130

Review 3.  Spinal cord ependymoma: a review of the literature and case series of ten patients.

Authors:  Emma Celano; Arsalaan Salehani; James G Malcolm; Erik Reinertsen; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2016-05-06       Impact factor: 4.130

4.  Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes.

Authors:  James E Bates; Gyujae Choi; Michael T Milano
Journal:  J Neurooncol       Date:  2016-06-15       Impact factor: 4.130

5.  Malignant peripheral nerve sheath tumor (MPNST) in the spine: a retrospective analysis of clinical and molecular prognostic factors.

Authors:  Ting Wang; Huabin Yin; Shuai Han; Xinhai Yang; Jing Wang; Quan Huang; Wangjun Yan; Wang Zhou; Jianru Xiao
Journal:  J Neurooncol       Date:  2015-01-20       Impact factor: 4.130

6.  Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas.

Authors:  Michael C Oh; Michael E Ivan; Matthew Z Sun; Gurvinder Kaur; Michael Safaee; Joseph M Kim; Eli T Sayegh; Derick Aranda; Andrew T Parsa
Journal:  Neuro Oncol       Date:  2012-12-09       Impact factor: 12.300

7.  A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal ependymoma.

Authors:  Ian David Connolly; Yingmei Li; Wenying Pan; Eli Johnson; Linya You; Hannes Vogel; John Ratliff; Melanie Hayden Gephart
Journal:  J Neurooncol       Date:  2017-09-12       Impact factor: 4.130

8.  Spinal ependymomas: benefits of extent of resection for different histological grades.

Authors:  Michael C Oh; Phiroz E Tarapore; Joseph M Kim; Matthew Z Sun; Michael Safaee; Gurvinder Kaur; Derick M Aranda; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2013-06-12       Impact factor: 1.961

9.  Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research Group.

Authors:  Sun-Ho Lee; Chun Kee Chung; Chi Heon Kim; Sang Hoon Yoon; Seung-Jae Hyun; Ki-Jeong Kim; Eun-Sang Kim; Whan Eoh; Hyun-Jib Kim
Journal:  Neuro Oncol       Date:  2013-04-10       Impact factor: 12.300

10.  Ependymomas of the filum terminale: The role of surgery and radiotherapy.

Authors:  Lars de Jong; Frank Van Calenbergh; Johan Menten; Johannes van Loon; Steven De Vleeschouwer; Christiaan Plets; Mehrnaz Didgar; Raf Sciot; Jan Goffin
Journal:  Surg Neurol Int       Date:  2012-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.